Investor Relations
|
Welcome to the Lilly investor relations site. Innovation is our passion -- achieving medical advances for patients who urgently need answers. The measure of our success is the strength of our products and pipeline and our ability to maximize their benefit. Explore this site to find more information about our breakthrough products and financial performance. |
|
Recent Releases
Sep 1, 2010
U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014
Stock Information
| NYSE:LLY
$34.18 - 0.02 |
Sep 2, 2010
3:32 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
